top of page
The Hockey Mom Foundation is an all volunteer organization that honors Hockey Moms everywhere by raising funds to make one time foundational donations to non-profits focused on furthering cancer research, and the care of cancer patients.

Honor a Hockey Mom

​

 

DONATE NOW!

Register for the

10th Annual Gator Open

Golf Outing Fundraiser 

Friday, September 19, 2025, Glen Oak Golf Club, East Amherst, NY

​

Picture1.png

Thanks to the generosity of our donors, friends, board, and volunteers, the HMF had the good fortune of providing grants to two cancer care/research programs at the close of 2024! Our 2025 donations total $45,000.

 

We granted $25,000 to Roswell Park Comprehensive Cancer Center for their Pediatric Palliative Care Partnership with Oishei Children's Hospital Pediatric Cancer and Blood Disorder Program. This program will support pediatric patients and families with a dedicated palliative care physician and advanced practice provider, aiming for improved pain and symptom management as well as optimized care coordination between palliative care,

primary medical, and psychosocial teams

 

Pictured, we presented Cleveland Clinic Lerner Research Institute a $20,000 grant. Masahiro Hitomi, MD, PhD,

and his collaborators are establishing a novel therapeutic sensitivity array using patient-derived cancer cells

to assist in treatment selection for patients with sarcoma, a rare type of tumor that develops in bone and

soft tissue. They have collected sarcoma cells to determine patient-specific anticancer drug sensitivity.

Testing various cell culture methods, the team aims to prepare a cell population that best represents

the tumor of the patient and establish quantitative measures to determine therapeutic sensitivity of

these cells. When established, this approach will provide data to reflect cancer cell susceptibility which

would minimize the chance of trial-and-error attempts, the drawback of current cancer treatment.

December 2023 grant of $25,000 for Car T-cell research at Roswell Park Cancer Institute

Hockey Mom Tournament Check Presentation 2.jpg

The Hockey Mom foundation represented the generosity of our donors by presenting a $25,000 check to Amanda Berg of the Roswell Park Alliance Foundation for a promising CAR T-cell therapy clinical trial. With therapy improvements in survival rates for patients with blood cancers, the team at Roswell Park is shifting focus to using their technology and discoveries to study CAR T-cell therapy on solid tumors like breast, lung, pediatrics, prostate and more. Renier Brentjens, MD, PhD is actively working on two clinical trials which look to improve CAR T-cell therapy. Those trials are in very early stages, but could bring about groundbreaking changes to the way cancer is treated.

IMG_0035.JPG

In July of 2023, we were thrilled to announce a $20,000 grant to positively impact pediatric patients in Cleveland Clinic Children's Better Care From Home initiative. Our grant went directly toward remote patient monitoring tools, reducing the number of hospital visits for kids going through chemo while simultaneously minimizing the risk of infections. Access to these remote caregiving tools (Wireless temperature monitoring patches, Wireless Blood Pressure cuffs, Activity Trackers similar to Fitbit and Digital Health Toolkits that include medical devices) significantly improve the quality of life during some of pediatric patient families’ most difficult times.

2022 Donation.png

In February of 2022, Hockey Mom Foundation presented a $25,000 grant
to Roswell Park Cancer Institutefor a very promising pediatric drug trial called Curaxin. 

With a successful trial, the benefits could be amazing for children with pediatric cancers. The favorable safety profile of Curaxin is boosted by the unique mechanism of action and these results support strong expectations for Curaxin’s success in the pediatric oncology arena. Dr. Katerina Gurova leads the Curaxin pediatric research at Roswell and we had the pleasure of meeting her during our check presentation. She shared that, of late
, children primarily receive adult chemotherapy treatments. These treatments are tough on adults, and even more painful for children. As one would expect given the enormous risks to children, pediatric trials are very difficult and expensive to administer. The National Cancer Institute’s Children’s Oncology Group (COG), the most reputable organization in the US that coordinates
international clinical trials for pediatric cancer patients, selected Curaxin for a multicenter clinical study

bottom of page